- Home
- ZM vs BNTX Comparison
ZM vs BNTX Comparison
Compare ZM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZM | BNTX |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.0B | 24.8B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZM | BNTX |
|---|---|---|
| Price | $89.42 | $94.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 11 |
| Target Price | $92.19 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 3.5M | 1.3M |
| Earning Date | 11-24-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.29 | N/A |
| EPS | ★ 5.13 | N/A |
| Revenue | ★ $4,805,915,000.00 | $3,698,814,972.00 |
| Revenue This Year | $7.19 | $2.36 |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | $17.45 | ★ N/A |
| Revenue Growth | ★ 3.85 | 3.70 |
| 52 Week Low | $64.41 | $81.20 |
| 52 Week High | $91.43 | $129.27 |
Technical Indicators
Market Signals| Indicator | ZM | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.72 | 38.15 |
| Support Level | $83.99 | $94.52 |
| Resistance Level | $89.58 | $97.35 |
| Average True Range (ATR) | 2.73 | 2.72 |
| MACD | 0.58 | -0.24 |
| Stochastic Oscillator | 84.41 | 8.21 |
Price Performance
Historical ComparisonAbout ZM Zoom Video Communications Inc.
Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company's cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.